Paper39172012
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Kortleve D and 20 others. Cancer Discov, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer. Papers, record 39172012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39172012
- Cell line
- HEK293T2,726 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
- PubMed
Connected records13
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines13
- HEK293TThe paper gives its RRID2,726 papers
- MDA-MB-231The paper gives its RRID845 papers
- K-562The paper gives its RRID341 papers
- BT-549The paper gives its RRID202 papers
- Hs 578TThe paper gives its RRID156 papers
- SUM159PTThe paper gives its RRID99 papers
- HCC1569The paper gives its RRID39 papers
- Phoenix-AmphoThe paper gives its RRID33 papers
- Evsa-TThe paper gives its RRID26 papers
- MDA-MB-435SThe paper gives its RRID23 papers
- SUM229PEThe paper gives its RRID20 papers
- BSMThe paper gives its RRID13 papers
- T2The paper gives its RRID6 papers
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Receptors, Antigen, T-Cell | Major topic |
| Humans | |
| Female | |
| Animals | |
| T-Lymphocytes | |
| Mice | |
| Cell Line, Tumor | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| EMC-TKI LSH20020 | Health∼Holland (LSH) | PubMed | ||
| n/a | Erasmus MC Daniel den Hoed Foundation | PubMed | ||
| 2014-7087 | KWF Kankerbestrijding (DCS) | PubMed |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21130497 | Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability. | Mol Immunol | 2011 | https://conductscience.org/library/papers/21130497 | PubMed |
| 2 | 19451549 | Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. | Blood | 2009 | https://conductscience.org/library/papers/19451549 | PubMed |
| 3 | 25414323 | Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25414323 | PubMed |
| 4 | 23423337 | Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity. | Mol Ther | 2013 | https://conductscience.org/library/papers/23423337 | PubMed |
| 5 | 10602881 | SYFPEITHI: database for MHC ligands and peptide motifs. | Immunogenetics | 1999 | https://conductscience.org/library/papers/10602881 | PubMed |
| 6 | 27869121 | Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. | Nat Commun | 2016 | https://conductscience.org/library/papers/27869121 | PubMed |
| 7 | 27558661 | Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients. | Sci Rep | 2016 | https://conductscience.org/library/papers/27558661 | PubMed |
| 8 | 27765921 | Triple-negative breast cancer: is there a treatment on the horizon? | Oncotarget | 2017 | https://conductscience.org/library/papers/27765921 | PubMed |
| 9 | 9679755 | Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. | Int J Cancer | 1998 | https://conductscience.org/library/papers/9679755 | PubMed |
| 10 | 29282079 | Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29282079 | PubMed |
| 11 | 12175724 | Prediction of MHC class I binding peptides using profile motifs. | Hum Immunol | 2002 | https://conductscience.org/library/papers/12175724 | PubMed |
| 12 | 23601657 | miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. | Breast Cancer Res | 2013 | https://conductscience.org/library/papers/23601657 | PubMed |
| 13 | 24518294 | β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. | Sci Signal | 2014 | https://conductscience.org/library/papers/24518294 | PubMed |
| 14 | 28366766 | Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers. | Mol Ther | 2017 | https://conductscience.org/library/papers/28366766 | PubMed |
| 15 | 15496961 | Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha. | Gene Ther | 2005 | https://conductscience.org/library/papers/15496961 | PubMed |
| 16 | 29929481 | Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons. | BMC Bioinformatics | 2018 | https://conductscience.org/library/papers/29929481 | PubMed |
| 17 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 18 | 22400038 | TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22400038 | PubMed |
| 19 | 16282986 | Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer. | Cancer Gene Ther | 2006 | https://conductscience.org/library/papers/16282986 | PubMed |
| 20 | 36185575 | Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma. | JHEP Rep | 2022 | https://conductscience.org/library/papers/36185575 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42321956 | Breathing new life into T-cell receptor-engineered T-cell therapy in solid tumors: enhancing strategies to expand the universality of precision therapy. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42321956 | PubMed |
| 42120393 | Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/42120393 | PubMed |
| 41948334 | Targeting the tripartite axis of immune-metabolic-spatial crosstalk to overcome therapy resistance in breast cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41948334 | PubMed |
| 41943836 | In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41943836 | PubMed |
| 41899515 | Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899515 | PubMed |
| 41039188 | Programmed cell death in triple-negative breast cancer. | Cell Mol Biol Lett | 2025 | https://conductscience.org/library/papers/41039188 | PubMed |
| 41007774 | Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007774 | PubMed |
| 40904610 | ROPN1 Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association. | Eur J Breast Health | 2025 | https://conductscience.org/library/papers/40904610 | PubMed |
| 40730190 | Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40730190 | PubMed |
| 40178291 | CD3xHER2 bsAb-Mediated Activation of Resting T-cells at HER2 Positive Tumor Clusters Is Sufficient to Trigger Bystander Eradication of Distant HER2 Negative Clusters Through IFNγ and TNFα. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40178291 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ROPN1 | 54763 | PubTator's text mining | https://conductscience.org/library/genes/54763 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39172012
GET https://conductscience.org/api/papers/v1/39172012/authors?page=2